Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy

Authors: Merriman, Katie M., Harmon, Stephanie A., Belue, Mason J., Yilmaz, Enis C., Blake, Zoë, Lay, Nathan S., Phelps, Tim E., Merino, Maria J., Parnes, Howard L., Law, Yan Mee

Source: AMERICAN JOURNAL OF ROENTGENOLOGY -NEW SERIES-. 221(6):773-785

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN632755125&indx=1&recIds=ETOCRN632755125

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance

Authors: Parsons, J. Kellogg, Pinto, Peter A., Pavlovich, Christian P., Uchio, Edward, Nguyen, Mike N., Kim, Hyung L., Gulley, James L., Sater, Houssein Abdul, Jamieson, Christina, Hsu, Chiu-Hsieh, Wojtowicz, Malgorzata, House, Margaret, Schlom, Jeffrey, Donahue, Renee N., Dahut, William L., Madan, Ravi A., Bailey, Shania, Centuori, Sara, Bauman, Julie E., Parnes, Howard L., Chow, H.-H. Sherry

Source: In European Urology Focus May 2023 9(3):447-454

Association of Serum Carotenoids and Retinoids with Intraprostatic Inflammation in Men without Prostate Cancer or Clinical Indication for Biopsy in the Placebo Arm of the Prostate Cancer Prevention Trial

Authors: Chadid, Susan, Song, Xiaoling, Schenk, Jeannette M., Gurel, Bora, Lucia, M. Scott, Thompson, Ian M., Neuhouser, Marian L., Goodman, Phyllis J., Parnes, Howard L., Lippman, Scott M., Nelson, William G., De Marzo, Angelo M., Platz, Elizabeth A.

Source: Nutrition and cancer. 74(1):141-148

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100141265553.0x000001&indx=1&recIds=ETOCvdc_100141265553.0x000001

Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening

Authors: Pierre-Victor, Dudith, Parnes, Howard L., Andriole, Gerald L., Pinsky, Paul F.

Source: In Urology September 2021 155:62-69

Magnetic Resonance Imaging-Targeted and Systematic Biopsy for Detection of Grade Progression in Patients on Active Surveillance for Prostate Cancer

Authors: Yerram, Nitin K., Long, Lori, O'Connor, Luke P., Wang, Alex Z., Ahdoot, Michael, Lebastchi, Amir H., Gurram, Sandeep, Zeng, Johnathan, Chalfin, Heather, Harmon, Stephanie A., Mehralivand, Sherif, Merino, Maria J., Parnes, Howard L., Choyke, Peter L., Shih, Joanna, Wood, Bradford J., Turkbey, Baris, Pinto, Peter A.

Source: Journal of urology. 205(5):1352-1360

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100184810324.0x000001&indx=1&recIds=ETOCvdc_100184810324.0x000001

A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance

Authors: Jarrard, David, Filon, Mikolaj, Huang, Wei, Havighurst, Tom, DeShong, Katina, Kim, KyungMann, Konety, Badrinath R., Saltzstein, Daniel, Mukhtar, Hasan, Wollmer, Barbara, Suen, Chen, House, Margaret G., Parnes, Howard L., Bailey, Howard H.

Source: Prostate. 81(1):41-49

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111478039.0x000001&indx=1&recIds=ETOCvdc_100111478039.0x000001

Long-Term Adverse Effects and Complications After Prostate Cancer Treatment.

Authors: Unger, Joseph M., Till, Cathee, Tangen, Catherine M., Hershman, Dawn L., Goodman, Phyllis J., LeBlanc, Michael, Barlow, William E., Vaidya, Riha, Minasian, Lori M., Parnes, Howard L., Thompson Jr, Ian M.

Source: JAMA Oncology; Dec2024, Vol. 10 Issue 12, p1654-1662, 9p

Combined MRI-targeted Plus Systematic Confirmatory Biopsy Improves Risk Stratification for Patients Enrolling on Active Surveillance for Prostate Cancer

Authors: O'Connor, Luke P., Wang, Alex Z., Yerram, Nitin K., Lebastchi, Amir H., Ahdoot, Michael, Gurram, Sandeep, Zeng, Johnathan, Mehralivand, Sherif, Harmon, Stephanie, Merino, Maria J., Parnes, Howard L., Choyke, Peter L., Turkbey, Baris, Wood, Bradford J., Pinto, Peter A.

Source: In Urology October 2020 144:164-170

Cabozantinib in patients with platinum-refractory metastatic urothelial carcinoma: an open-label, single-centre, phase 2 trial

Authors: Apolo, Andrea B ^*, Nadal, Rosa, Tomita, Yusuke, Davarpanah, Nicole N, Cordes, Lisa M, Steinberg, Seth M, Cao, Liang, Parnes, Howard L, Costello, Rene, Merino, Maria J, Folio, Les R, Lindenberg, Liza, Raffeld, Mark, Lin, Jeffrey, Lee, Min-Jung, Lee, Sunmin, Alarcon, Sylvia V, Yuno, Akira, Dawson, Nancy A, Allette, Kimaada, Roy, Arpita, De Silva, Dinuka, Lee, Molly M, Sissung, Tristan M, Figg, William D, Agarwal, Piyush K, Wright, John J, Ning, Yangmin M, Gulley, James L, Dahut, William L, Bottaro, Donald P, Trepel, Jane B

Source: In The Lancet Oncology August 2020 21(8):1099-1109

The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial

Authors: Chadid, Susan, Barber, John R., Nelson, William G., Gurel, Bora, Lucia, M. Scott, Thompson, Ian M., Goodman, Phyllis J., Stanczyk, Frank Z., Parnes, Howard L., Lippman, Scott M., De Marzo, Angelo M., Platz, Elizabeth A.

Source: Prostate. 80(11):895-905

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107629846.0x000001&indx=1&recIds=ETOCvdc_100107629846.0x000001

Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort

Authors: Nguyen, Mike M., Martinez, Jessica A., Hsu, Chiu-Hsieh, Sokoloff, Mitchell, Krouse, Robert S., Gibson, Blake A., Nagle, Raymond B., Parnes, Howard L., Cordova, Catherine, Chow, H-H. Sherry

Source: European Journal of Cancer Prevention, 2018 Nov 01. 27(6), 557-562.

Access URL: https://www.jstor.org/stable/48504731

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: The Role of a Negative Confirmatory MRI-US Fusion Biopsy

Authors: Bloom, Jonathan B., Hale, Graham, Gold, Samuel A., Rayn, Kareem, Smith, Clayton, Mehralivand, Sherif, Czarniecki, Marcin, Valera, Vladimir, Wood, Bradford J., Merino, Maria, Choyke, Peter L., Parnes, Howard L., Turkbey, Baris, Pinto, Peter A.

Source: In The Journal of Urology July 2018

Use of multiparametric magnetic resonance imaging and fusion‐guided biopsies to properly select and follow African‐American men on active surveillance

Authors: Bloom, Jonathan B., Lebastchi, Amir H., Gold, Samuel A., Hale, Graham R., Sanford, Thomas, Mehralivand, Sherif, Ahdoot, Michael, Rayn, Kareem N., Czarniecki, Marcin, Smith, Clayton, Valera, Vladimir, Wood, Bradford J., Merino, Maria J., Choyke, Peter L., Parnes, Howard L., Turkbey, Baris, Pinto, Peter A.

Source: BJU international. 124(5):768-774

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100091277213.0x000001&indx=1&recIds=ETOCvdc_100091277213.0x000001

Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients

Authors: Bloom, Jonathan B. ^*, Daneshvar, Michael A. ^*, Lebastchi, Amir H., Ahdoot, Michael, Gold, Samuel A., Hale, Graham, Mehralivand, Sherif, Sanford, Thomas, Valera, Vladimir, Wood, Bradford J., Choyke, Peter L., Merino, Maria J., Turkbey, Baris, Parnes, Howard L., Pinto, Peter A.

Source: In Urologic Oncology: Seminars and Original Investigations October 2021 39(10):729-729

Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer

Authors: Frye, Thomas P., George, Arvin K., Kilchevsky, Amichai, Maruf, Mahir, Siddiqui, M. Minhaj, Kongnyuy, Michael, Muthigi, Akhil, Han, Hui, Parnes, Howard L., Merino, Maria, Choyke, Peter L., Turkbey, Baris, Wood, Brad, Pinto, Peter A.

Source: In The Journal of Urology March 2017 197(3) Part 1:640-646

A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial Carcinoma

Authors: Apolo, Andrea B., Karzai, Fatima H., Trepel, Jane B., Alarcon, Sylvia, Lee, Sunmin, Lee, Min-Jung, Tomita, Yusuke, Cao, Liang, Yu, Yunkai, Merino, Maria J., Madan, Ravi A., Parnes, Howard L., Steinberg, Seth M., Rodriguez, Beatriz Walter, Seon, Ben K., Gulley, James L., Arlen, Philip M., Dawson, Nancy A., Figg, William D., Dahut, William L.

Source: In Clinical Genitourinary Cancer February 2017 15(1):77-85

Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer

Authors: Kim, Jeri, Davis, John W., Klein, Eric A., Magi-Galluzzi, Cristina, Lotan, Yair, Ward, John F., Pisters, Louis L., Basler, Joseph W., Pettaway, Curtis A., Stephenson, Andrew, Li Ning Tapia, Elsa M., Efstathiou, Eleni, Wang, Xuemei, Do, Kim-Anh, Lee, J. Jack, Gorlov, Ivan P., Vornik, Lana A., Hoque, Ashraful M., Prokhorova, Ina N., Parnes, Howard L., Lippman, Scott M., Thompson, Ian M., Brown, Powel H., Logothetis, Christopher J., Troncoso, Patricia

Source: In EBioMedicine May 2016 7:85-93

Effect of Finasteride on Serum Androstenedione and Risk of Prostate Cancer Within the Prostate Cancer Prevention Trial: Differential Effect on High- and Low-grade Disease

Authors: Hoque, Ashraful, Yao, Song, Till, Cathee, Kristal, Alan R., Goodman, Phyllis J., Hsing, Ann W., Tangen, Catherine M., Platz, Elizabeth A., Stanczyk, Frank Z., Reichardt, Juergen K.V., vanBokhoven, Adrie, Neuhouser, Marian L., Santella, Regina M., Figg, William D., Price, Douglas K., Parnes, Howard L., Lippman, Scott M., Ambrosone, Christine B., Thompson, Ian M.

Source: In Urology March 2015 85(3):616-620

Prevention and early detection of prostate cancer

Authors: Cuzick, Jack, Thorat, Mangesh A, Andriole, Gerald, Brawley, Otis W, Brown, Powel H, Culig, Zoran, Eeles, Rosalind A, Ford, Leslie G, Hamdy, Freddie C, Holmberg, Lars, Ilic, Dragan, Key, Timothy J, Vecchia, Carlo La, Lilja, Hans, Marberger, Michael, Meyskens, Frank L, Minasian, Lori M, Parker, Chris, Parnes, Howard L, Perner, Sven, Rittenhouse, Harry, Schalken, Jack, Schmid, Hans-Peter, Schmitz-Dräger, Bernd J, Schröder, Fritz H, Stenzl, Arnulf, Tombal, Bertrand, Wilt, Timothy J, Wolk, Alicja

Source: In Lancet Oncology October 2014 15(11):e484-e492

Statin Drug Use is Not Associated with Prostate Cancer Risk in Men Who are Regularly Screened

Authors: Platz, Elizabeth A., Tangen, Catherine M., Goodman, Phyllis J., Till, Cathee, Parnes, Howard L., Figg, William D., Albanes, Demetrius, Neuhouser, Marian L., Klein, Eric A., Lucia, M. Scott, Thompson, Ian M., Jr., Kristal, Alan R.

Source: In The Journal of Urology August 2014 192(2):379-384